Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ... [Yahoo! Finance]
Clearside Biomedical, Inc. (CLSD)
Last clearside biomedical, inc. earnings: 3/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.clearsidebio.com/investor-overview
Company Research
Source: Yahoo! Finance
Clearside Biomedical Inc ( NASDAQ:CLSD ) reported positive results from the Odyssey phase two B clinical trial for wet AMD, demonstrating potential efficacy and safety of CLS AX. The company is the only TKI Wet AMD program with repeat dosing data, providing a competitive advantage as they advance CLS AX into phase three. Clearside's SCS microinjector has been successfully used in over 10,000 injections, showcasing its safety and reliability. The company has solidified its formulation expertise and has commercial scale microinjector manufacturing capability with ISO certification. Clearside's collaboration with Arctic Vision and Santan Pharmaceuticals highlights strategic validation of their super choroidal delivery platform. Clearside Biomedical Inc ( NASDAQ:CLSD ) has cash and cash equivalents totaling $23.6 million, which is only sufficient to fund operations into the third quarter of 2025. The company is still in the planning stages for the phase three trial of CLS AX,
Show less
Read more
Impact Snapshot
Event Time:
CLSD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLSD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLSD alerts
High impacting Clearside Biomedical, Inc. news events
Weekly update
A roundup of the hottest topics
CLSD
News
- Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.MarketBeat
- Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.MarketBeat
- Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateGlobeNewswire
- Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Report Preview: What to Look For [Yahoo! Finance]Yahoo! Finance
CLSD
Earnings
- 11/12/24 - Beat
CLSD
Sec Filings
- 11/12/24 - Form 10-Q
- 11/12/24 - Form 8-K
- 11/4/24 - Form 4
- CLSD's page on the SEC website